Multiparametric MRI (mpMRI) findings are not always accurate in patients with a previous negative prostate biopsy. Truong et al. have developed a nomogram to identify patients with previous negative prostate biopsy who are at elevated risk of harbouring benign histology and should undergo repeat biopsy.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bokhorst, L. P. et al. Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial. BJU Int. 110, 1654–1660 (2012).
Takenaka, A. et al. A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy. Prostate Cancer Prostat. Dis. 11, 134–138 (2008).
Campos-Fernandes, J.-L. et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur. Urol. 55, 600–609 (2009).
Prostate Cancer Guidelines Panel. Prostate Cancer. European Association of Urology http://uroweb.org/guideline/prostate-cancer/ (2017).
Truong, M. et al. Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy. Cancer http://dx.doi.org/10.1002/cncr.31051 (2017).
Rosenkrantz, A. B. et al. Proposed adjustments to PI-RADS version 2 decision rules: impact on prostate cancer detection. Radiology 283, 119–129 (2016).
Thompson, J. E. et al. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J. Urol. 192, 67–74 (2014).
Venderink, W. et al. Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2017.02.021 (2017).
Liddell, H., Jyoti, R. & Haxhimolla, H. Z. mp-MRI prostate characterised PIRADS 3 lesions are associated with a low risk of clinically significant prostate cancer — a retrospective review of 92 biopsied PIRADS 3 lesions. Curr. Urol. 8, 96–100 (2015).
Edwan, G. A. et al. Magnetic resonance imaging detected prostate evasive anterior tumours: further insights. Can. Urol. Assoc. J. 9, E267–E272 (2015).
Acknowledgements
The authors thank M. Marchioni, F. Preisser and M. Bandini for their help in researching data for the article and review and editing of the manuscript before submission.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Karakiewicz, P., Nazzani, S. A valuable tool for prediction of repeat biopsy pathology. Nat Rev Urol 15, 140–141 (2018). https://doi.org/10.1038/nrurol.2017.216
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2017.216
This article is cited by
-
Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases (2019)
